Dr Reddy's launches blood pressure drug in U.S

Dr Reddy's Laboratories said it has launched chlorthalidone tablets, used to treat high blood pressure, in the U.S market.

Dr Reddy's Laboratories Ltd launched Chlorthalidone tablets USP in the strengths of 25 mg and 50 mg, a therapeutic equivalent generic version of Hygroton tablets, Dr Reddy's Laboratories said in a BSE filing.

Quoting IMS Health data, Dr Reddy's Laboratories said, the Hygroton brand and its generic had U.S sales of approximately USD 122 million for the twelve months ending in September 2018.